Daratumumab for the Treatment of Relapsed/Refractory Multiple Myeloma: A Single Center Experience

2017 ◽  
Vol 17 (1) ◽  
pp. e67-e68
Author(s):  
Victor Jimenez-Zepeda ◽  
Peter Duggan ◽  
Paola Neri ◽  
Joanne Luider ◽  
Jason Tay ◽  
...  
Keyword(s):  
Multiple Myeloma ◽  
Single Center ◽  
Refractory Multiple Myeloma ◽  
Single Center Experience

Carfilzomib in Relapsed/Refractory Multiple Myeloma, Single Center Experience

2015 ◽  
Vol 15 ◽  
pp. e306-e307
Author(s):  
Y. Aydin ◽  
I. Erdogan ◽  
A. Salihoglu ◽  
T. Elverdi ◽  
F.F. Yalniz ◽  
...  
Keyword(s):  
Multiple Myeloma ◽  
Single Center ◽  
Refractory Multiple Myeloma ◽  
Single Center Experience

Pomalidomide in Refractory Multiple Myeloma (MMRR): A Single Center Experience

2015 ◽  
Vol 15 ◽  
pp. e311
Author(s):  
C. Montes-Gaisan ◽  
C. Montes-Gaisán ◽  
A. Cuesta ◽  
A. Bermúdez ◽  
A. Insunza ◽  
...  
Keyword(s):  
Multiple Myeloma ◽  
Single Center ◽  
Refractory Multiple Myeloma ◽  
Single Center Experience

scholarly journals PB2184 CARFILZOMIB OR POMALIDOMIDE IN PATIENTS WITH RELAPSE AND/OR REFRACTORY MULTIPLE MYELOMA: SINGLE CENTER EXPERIENCE

HemaSphere ◽  
2019 ◽  
Vol 3 (S1) ◽  
pp. 980
Author(s):  
A. Arslan ◽  
F. Keklik Karadağ ◽  
Y. Ulusoy ◽  
H. Bülbül ◽  
E. Arslan Davulcu ◽  
...  
Keyword(s):  
Multiple Myeloma ◽  
Single Center ◽  
Refractory Multiple Myeloma ◽  
Single Center Experience

scholarly journals Outcome of COVID-19 infection in 50 multiple myeloma patients treated with novel drugs: single-center experience

2021 ◽  
Author(s):  
Marta Krejci ◽  
Ludek Pour ◽  
Zdenek Adam ◽  
Viera Sandecka ◽  
Martin Stork ◽  
...  
Keyword(s):  
Multiple Myeloma ◽  
Single Center ◽  
Single Center Experience ◽  
Novel Drugs
Sign in / Sign up

Export Citation Format

Share Document